UBS Maintains Buy on Visteon, Lowers Price Target to $107
UBS analyst Joseph Spak maintains Visteon (NASDAQ:VC) with a Buy and lowers the price target from $130 to $107.
Share
Why It Matters
A big bank analyst still likes Visteon but thinks it is worth less money now. When experts lower their price targets, watch if the company is facing real challenges.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.